HRT Financial’s Korro Bio KRRO Stock Holding History

HRT Financial’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122K	Buy	+10,790	New	+$119K	﹤0.01%	3310
2025 Q1	–	Sell	-5,703	Closed	-$217K	–	2980
2024 Q4	$217K	Sell	5,703 -939	-14%	-$48.3K	﹤0.01%	1891
2024 Q3	$221K	Sell	6,642 -25,882	-80%	-$1.09M	﹤0.01%	1934
2024 Q2	$1.1M	Buy	+32,524	New	+$1.8M	0.01%	977
2023 Q4	–	Sell	-294	Closed	-$5K	–	2725
2023 Q3	$5K	Buy	+294	New	+$7.37K	﹤0.01%	2181
2021 Q4	–	Sell	-549	Closed	-$193K	–	3655
2021 Q3	$193K	Buy	+549	New	+$216K	﹤0.01%	2704

Other funds holding KRRO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRT Financial's KRRO Position: Q1 2026 in Review

HRT Financial opened a new position in Korro Bio (KRRO) in Q1 2026: 10,790 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #3310 among its holdings. This is a return to the name: HRT Financial previously reported a position in KRRO as recently as Q4 2024.

HRT Financial first reported a position in KRRO in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.1M in Q2 2024. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

HRT Financial held 10,790 shares of Korro Bio worth $122K as of Q1 2026.
Korro Bio was a new HRT Financial position in Q1 2026.
Korro Bio made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3310 holding.
HRT Financial first reported a position in Korro Bio in Q3 2021 and has held it in 6 quarters since.
HRT Financial's Korro Bio position peaked at $1.1M in Q2 2024.
99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.